![](https://ml.globenewswire.com/media/3014e7dd-b906-43bd-a382-76ea9eec5a35/small/anbio-logo-png.png)
Anbio Biotechnology Announces Pricing of Initial Public Offering
Frankfurt am Main, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical technology and the provision of in vitro diagnostics products, today announced …